The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats (original) (raw)

Abstract

A rat warm-water tail-withdrawal procedure was used to examine the effects of chronic administration of the competitive NMDA receptor antagonist LY235959 in morphine tolerant rats. Morphine dose-dependently increased tail-withdrawal latencies from 55°C water. When morphine (10 mg/kg) was administered twice-daily for 7 days, the morphine dose-effect curves shifted 0.3–0.5 log unit to the right. When morphine was administered for an additional 7 days, the morphine dose-effect curve shifted 0.4 log unit further to the right. Co-administration of LY235959 (1, 3, 10 mg/kg) along with morphine prevented the development of tolerance observed during the second week of chronic morphine administration. Although the highest dose of LY235959 (10 mg/kg) partially reversed tolerance in five of seven rats, tolerance was not reversed by lower doses of LY235959. These data suggest that NMDA receptor antagonists may effectively prevent the progressive development of morphine tolerance at doses that are not sufficient to reverse pre-established morphine tolerance.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Curriculum in Neurobiology, c/o Department of Psychology, CB# 3270, Davie Hall, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599–3270, USA e-mail: rmallen@med.unc.edu, Fax: +1-919-962-2537, , , , , , US
    R. M. Allen & Linda A. Dykstra

Authors

  1. R. M. Allen
    You can also search for this author inPubMed Google Scholar
  2. Linda A. Dykstra
    You can also search for this author inPubMed Google Scholar

Additional information

Received: 10 June 1998/Final version: 19 August 1998

Rights and permissions

About this article

Cite this article

Allen, R., Dykstra, L. The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats.Psychopharmacology 142, 209–214 (1999). https://doi.org/10.1007/s002130050881

Download citation